Exam 2 Flashcards

1
Q

Anticholinergics- medications

A

atropine
ipratropium
scopolamine
glycopyrrolate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Anticholinergics- MOA

A

inhibits action of acetylcholine and neurotransmitters to decrease secretions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

aniticholinergic SE

A

constipation, dry eye, dry mucous membranes, blurry vision, tachycardia, GI obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

anticholinergic- Considerations

A

monitor I and O (urinary retension, constipation)
antacids decrease absorption of these meds
VS (hypotension and tachycardia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Anticholinergics- teaching

A

teach about oral care
may cause drowsiness
do not admin with a fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Leukotriene Receptor Antagonists- meds

A

montelukast
zafirlukast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

LTRA- MOA

A

stops the effects of leukotrienes in the body (narrowing of airways, and smooth muscle constriction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

LTRA SE

A

SJS, increased liver enzymes, depression/suicidal thoughts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

LTRA- considerations

A

monitor ALT and AST
assess lung sounds, respiratory status
assess mood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

LTRA- teaching

A

its long acting, do not take during flare
take daily at night or 2 hours prior to exercise
educate to report any feelings of depression or suicidal thoughts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

mast cell stabilizers- med

A

cromolyn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

mast cell stabalizers- MOA

A

decreases release of histamine, good for preventing exercise induced asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

mast cell stabilizers- SE

A

nasal, throat, or trachea irritation
wheezing
nausea
unpleasant taste
cough

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

mast cell stabilizers- considerations

A

assess lung sounds and respirator function
intranasal- assess for symptoms of rhinitis and rhinorrhea
reduction of other asthma med may be possible after 2-4 wks of therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

mast cell stabilizers-teaching

A

instruct on correct use of med (use routinely, don’t double dose, don’t discontinue without consulting HCP)
administer 10-15min prior to exposure of known allergy and no earlier than 60 min in advance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Inhaled corticosteroids- meds

A

beclomethasone dipropionate
budesonide
ciclesonide
flunisolide
fluticasone
momestasone
triameinolone acetonide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

inhaled corticosteroids- MOA

A

locally acting/suppressing inflammation and enhancing beta agonist response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

inhaled corticosteroids- SE

A

oral thrush/dry mouth
coughing
infections
pharyngeal irritation
chest pain/ dizziness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

inhaled corticosteroids- considerations

A

no systemic effects when inhaled
use bronchodilator before inhaled corticosteroid, all 5 min before admin of corticosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

inhaled corticosteroids- teaching

A

rinse mouth after use

21
Q

LABA- meds

A

salmeterol, formoterol

22
Q

LABA- MOA

A

bronchodilation

23
Q

LABA- SE

A

headache
cough
tachycardia
HTN
paradoxical
bronchospasm
nervousness

24
Q

LABA- considerations

A

assess lung sounds, pulse, BP
use with MAOI and TCA may potentiate effects

25
LABA- teaching
instruct patient using powder for inhalation never to exhale into diskus device and always to hold device in a level horizontal position. mouthpiece should be kept dry, never wash Use in combination with ICS
26
monoclonal antibody- meds
omalizumab
27
monoclonal antibody- MOA
blocks inflammatory response
28
monoclonal antibody SE
MI, DVT, infection site reaction
29
monoclonal antibody- considerations
assess lung sounds and respiratory rate assess for allergic reaction or s/s of MI and DVT
30
monoclonal antibody- teaching
don't decrease or discontinue other asthma meds, especially inhaled corticosteroids call HCP for s/s or allergic reaction
31
short-acting beta2 agonist- med
albuterol levalbuterol
32
short acting- MOA
relaxation of airway of smooth muscle with subsequent bronchodilation
33
short-acting- SE
hyperactivity hyperglycemia hypokalemia tremor headache nervousness paradoxical bronchospasm
34
short-acting- considerations
assess lung sounds monitor pt for adverse effect observe for paradoxical bronchospasm
35
short-acting- teaching
educate on proper technique advise to use 1st if concurrent use with other inhaler medications notify HCP if breathing not improved or worsens
36
benzodiazepines- meds
diazepam, midazolam, alprazolam
37
hydantoi derivatives- meds
phenytoin, fosphenytoin
38
barbiturates- meds
phenobarbital
39
iminostilbenes- meds
carbamazepine, oxcarbazepine
40
suicidal thoughts and behavior
all
41
dizziness and drowsiness
all
42
reduce other medication efficacy
benzodiazepines, hydantoin derivatives, iminostilbenes
43
gingival hyperplasia and increased body hair
hydantoin derivatives
44
vision loss
vigabatrin
45
weight loss, impaired cognition and language difficulties
topiramate
46
weight gain, insulin resistance and metabolic syndrome
iminostilbenes, valproic acid, gabapentin
47
SIADH
iminostilbenes
48
rescue med
benzodiazepines
49
CBC and liver function testing regularly
all